JCI
AGN

Jet Capital Investors’s Allergan plc AGN Stock Holding History

Jet Capital Investors’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-87,804
Closed -$26.1M – 71
2015
Q1 		$26.1M Sell
87,804
-12,196
-12% -$3.48M 0.79% 41
2014
Q4 		$25.7M Sell
100,000
-100,000
-50% -$25M 0.95% 32
2014
Q3 		$48.3M Buy
+200,000
New +$44.8M 1.78% 21

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Jet Capital Investors's AGN Position: Q2 2020 in Review

Jet Capital Investors sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 84,958 shares — an estimated $15M sold.

Jet Capital Investors first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $56.7M in Q3 2014. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Jet Capital Investors reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Jet Capital Investors sold 84,958 Allergan plc shares in Q2 2020, an estimated $15M.
  • Jet Capital Investors first reported a position in Allergan plc in Q2 2013 and held it in 7 quarters.
  • Jet Capital Investors's Allergan plc position peaked at $56.7M in Q3 2014.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Jet Capital Investors's 13F filing for Q2 2020, filed 14 Aug 2020.